Fresh2 Group LimitedPrefunded American Depositary Shares Purchase Warrant Exercise Letter Agreement • June 24th, 2024 • Citibank,N.A./ADR • Services-medical laboratories
We refer to the Deposit Agreement, dated as of February 3, 2020, by and among Fresh2 Group Limited (formerly known as “Anpac Bio-Medical Science Co. Ltd.”) (the “Company”), Citibank, N.A., as depositary (the “Depositary”), and all Holders and Beneficial Owners of American Depositary Shares (“ADSs”) issued thereunder, as amended by Amendment No. 1 to the Deposit Agreement, dated as of November 4, 2022 (as so amended and supplemented, the “ADS Deposit Agreement”). Terms used, but not otherwise defined, herein shall have the meaning ascribed to them in the ADS Deposit Agreement.
